Opus Genetics Inc.

04/22/2026 | Press release | Distributed by Public on 04/22/2026 04:16

Proxy Results (Form 8-K)

Item 5.07.
Submission of Matters to a Vote of Security Holders.
At the 2026 annual meeting of stockholders (the "Annual Meeting") of Opus Genetics, Inc. (the "Company"), held on April 20, 2026, the Company's stockholders (i) elected nine directors to the board of directors of the Company, each to serve a one-year term until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation, or removal (the "Board Election Proposal"), (ii) ratified the appointment of Ernst & Young, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 (the "Auditor Ratification Proposal"), (iii) approved, on an advisory basis, the compensation of the Company's named executive officers (the "Say-On-Pay Proposal"), and (iv) approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's common stock from 125 million shares to 250 million shares (the "Stock Increase Proposal").
The results of the voting at the Annual Meeting are shown below:
Proposal 1 - Board Election Proposal:
Nominee
Votes For
Votes Withheld
Broker Non-Votes
Sean Ainsworth
35,063,423
169,848
12,043,097
Dr. Jean Bennett
35,005,873
227,398
12,043,097
Susan K. Benton
35,018,757
214,514
12,043,097
Cam Gallagher
35,020,569
212,702
12,043,097
Dr. Adrienne Graves
35,025,204
208,067
12,043,097
Dr. George Magrath
35,054,118
179,153
12,043,097
Dr. James S. Manuso
33,885,159
1,348,112
12,043,097
Richard Rodgers
35,049,948
183,323
12,043,097
Dr. Benjamin R. Yerxa
35,051,244
182,027
12,043,097

Proposal 2 - Auditor Ratification Proposal:
Votes For
Votes Against
Abstentions
46,844,680
315,324
116,364

Proposal 3 - Say-On-Pay Proposal:
Votes For
Votes Against
Abstentions
Broker Non-Votes
34,862,743
259,749
110,779
12,043,097

Proposal 4 - Stock Increase Proposal:

Votes For
Votes Against
Abstentions
45,360,642
1,486,247
429,479

Opus Genetics Inc. published this content on April 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 22, 2026 at 10:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]